Costs of Care for Dementia Patients in Community Setting: An Analysis for Mild and Moderate Disease Stage  by Schwarzkopf, Larissa et al.
Gfi
o
g
p
f
s
s
h
V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 8 2 7 – 8 3 5
Avai lable onl ine at www.sc iencedirect .com
journal homepage: www.elsevier .com/ locate / jva lCosts of Care for Dementia Patients in Community Setting: An Analysis
for Mild and Moderate Disease Stage
Larissa Schwarzkopf1,*, Petra Menn, PhD1, Simone Kunz, PhD1, Rolf Holle, PhD1, Jörg Lauterberg, PhD2, Peter Marx3,
Hilmar Mehlig4, Sonja Wunder, PhD5, Reiner Leidl, PhD1, Carolin Donath, PhD6, Elmar Graessel, PhD6
1Helmholtz Zentrum München/Institute of Health Economics and Health Care Management, Neuherberg, Germany; 2Federal Association of the AOK, Berlin,
ermany; 3Pfizer Deutschland GmbH, Berlin, Germany; 4Eisai GmbH, Frankfurt, Germany; 5AOK Bavaria – Health Insurer, Nuremberg, Germany; 6UniversityHospital Erlangen/Clinic for Psychiatry and Psychotherapy, Erlangen, GermanyA B S T R A C Tt
s
c
t
w
m
f
g
p
p
K
d
m
CObjective: Rising life expectancy is associated with higher prevalence
rates of dementia disorders. When disease progresses the patients’ call
on formal health care services and on social support grows which im-
poses increasing costs of care. The aim of this study was to investigate
the costs for patients with mild and moderate dementia in community
setting in Germany. Methods: We assessed total costs of care and in-
dividual cost components for 383 community-living dementia patients
alongside a cluster-randomized trial from societal and health insur-
ance perspective. Utilization of formal health care services was based
on insurance claims data and time dedicated to informal care was
assessed within caregiver interviews. We estimated costs using a two-
part regression model adjusting for age, gender and cluster-effects.
Results: Costs of care equal €47,747 (Euros) from societal perspective
which is almost the 4.7-fold of health insurance expenditures. Valued
informal care covers 80.2% of societal costs and increases dispropor- O
ntru
ent, I
al So
doi:10.1016/j.jval.2011.04.005ionally when disease progresses. In moderate dementia the corre-
ponding amount exceeds the one in mild dementia by 69.9%, whereas
osts for formal health care services differ by 14.3%. Conclusion: Due
o valued informal care, costs of care for community-living patients
ith moderate dementia are significantly higher than for patients with
ild dementia. Informal care is a non-cash item saving expenditures
or professional care. To relieve social security system and family care-
ivers as well as to allow dementia patients to stay at home as long as
ossible, concepts fostering community-based dementia care and sup-
ort to family caregivers need to be further developed.
eywords: administrative data, cognition, community-living patient,
isease severity, family caregiver, health insurance perspective, infor-
al care, insurance claims data, MMSE, societal perspective.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Currently about 1.2 million people in Germany aged 65 years and
older are expected to suffer from dementia equating 7% of the
corresponding age group [1]. Similar prevalence rates have been
estimated for other Europeans countries [2]. Rising life expectancy
is associated with an increasing risk of developing dementia dis-
orders, thus a further increase can be expected [3]. Assuming con-
stant incidence and prevalence rates, demographic change alone
has been argued to increase the number of people with dementia
in Germany between 2007 and 2030 by 51% [4].
In most cases, family members of dementia patients are the
rst to take over care giving and supervision tasks. Due to a change
f traditional living arrangements within the past decades, a
rowing number of elderly people live on their own without sup-
ort of family members. This poses an enormous challenge on the
uture organization of dementia care and its financing via social
ecurity systems all over the world.
Within the last 20 years, several studies examined the relation-
hip between disease stage and costs of dementia care, be it from
ealth insurance’s or from society’s point of view. Related re-
* Address correspondence to: Larissa Schwarzkopf, Helmholtz Ze
(GmbH), Institute of Health Economics and Health Care Managem
E-mail: l.schwarzkopf@helmholtz-muenchen.de.
1098-3015/$36.00 – see front matter Copyright © 2011, Internation
Published by Elsevier Inc.search in large part either especially targeted at Alzheimer’s de-
mentia [5–9] or referred to the US-American [9–11] and Scandina-
vian context [12–14]. Against this background, Quentin and
collaborators compared 28 studies on costs of dementia care [15].
Despite differences in methodology, setting and timeframe they
found broad consensus within the scientific community that costs
of care rise with cognitive decline. Taking also into account com-
plementary measures of disease severity such as behavior and
functional status Mauskopf and collaborators draw the same con-
clusion within a recent review [7].
Even if the commonplace equation “the further disease pro-
gression the higher the costs of care” is intuitively convincing,
however, it might oversimplify the complex framework of demen-
tia care. Scuvee-Moreau et al. [16], for example, pointed out that
stage-dependant costs of dementia care have a parabolic curve
with moderate cases being less costly than mild or severe ones.
The reasons for this phenomenon remain unclear.
Stage-dependant cost analyses of dementia care addressing
various health care sectors are scarce in Germany. In the late 1990s
Hallauer et al. [17] interviewed physicians, staff of nursing services
and nursing homes as well as family members of Alzheimer pa-
m München, German Research Center for Environmental Health
ngolstaedter Landstrasse 1, 85764 Neuherberg, Germany.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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828 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 8 2 7 – 8 3 5tients in order to estimate the costs of Alzheimer care based on the
personal experiences of their interview partners. Meanwhile not
only the institutional framework but also the standards of demen-
tia therapy have changed.
Referring to more recent cost estimates from other countries
might lead to deceptive conclusions because service utilization,
treatment decisions and unit costs differ across health care sys-
tems.
Lately Germany participated in “ICTUS” a multinational project
on Alzheimer’s that compared costs of care within 12 European
countries. To investigate regional differences this study assessed
resource use for 1 month cross-nationally via RUD-Lite, extrapo-
lated obtained data to per-year figures and applied a common
price vector [8].
A cost assessment of community based dementia care that is
exclusively focused on Germany and accounts for all cost catego-
ries of relevance with emphasis on the differences between soci-
etal perspective and health insurance perspective is missing so
far. This article aims at closing the knowledge gap described above
combining primary data and insurance claims data collected
alongside the cluster-randomized intervention study “IDA” (Initia-
tive Demenzversorgung in der Allgemeinmedizin, or dementia
care initiative in primary practice).
The three objectives of this article are: 1) to examine the yearly
costs of community-based care for dementia patients from soci-
etal perspective and from perspective of statutory health insur-
ance; 2) to describe costs of care within various service categories
according to disease severity given societal perspective; and 3) to
highlight service categories with relevant differences between the
distinct disease stages.
Methods
Study
The German IDA project was designed as a three-armed cluster-
randomized trial in the study region Middle Franconia, Bavaria,
with the main interest to analyze whether family counseling is an
appropriate strategy to delay nursing home placement. As a sec-
ondary objective costs of dementia care in community setting
were investigated. The intervention period ranged over 24 months
starting from the individual point of study entry, with death or
permanent nursing home placement as endpoints for a premature
discontinuation of the observation.
Community-living individuals suffering from mild to moderate
dementia were recruited from June 2005 to December 2006 via
their general practitioners. Dementia patients insured with AOK
Bavaria Health Insurance Fund who lived in community setting
and were aged 65 years or older could participate, if they had sup-
port of an informal caregiver and if they scored from 10 to 24
points in the mini-mental-status examination (MMSE). Exclusion
criteria were the presence of a terminal disease or a planned nurs-
ing home placement.
General practitioners (GPs) who were willing to participate re-
ceived detailed information of IDA design and special training on
dementia diagnosis prior to patient enrollment. GPs were after-
wards asked to get in contact with potential study participants
amongst their patient clientele. Signed informed consent of pa-
tients and informal caregivers was required before study inclu-
sion. One hundred twenty nine GPs participated and registered a
total of 390 patients of whom 7 later withdrew their consent. Fur-
ther information on study design, recruitment strategy, and GP
training has been published elsewhere [18,19].
The IDA study was approved by the Ethics Committee at the
Bavarian Chamber of Physicians.Patients’ characteristics and care giving environment
Within a baseline examination, the general practitioners con-
ducted the MMSE for all patients and confirmed a differential di-
agnosis of dementia. In addition they reported time of first demen-
tia diagnosis, history of previous anti-dementia drug prescriptions
and the presence of up to five comorbid conditions.
The MMSE is a well established method to define different
stages of cognitive impairment. It works with a scale ranging from
0 to 30 points, where lower values represent higher cognitive im-
pairment [20]. We categorized participants with an MMSE score
from 10 to 17 (n  135) as moderate dementia and those with an
MSE score from 18 to 24 (n  248) as mild dementia, which cor-
esponds with previous classifications [21,22].
Additionally trained interviewers conducted a baseline tele-
hone interview with the main caregivers of the patients. Within
his interview we asked our interview partners to name the pri-
ary caregiver if they were not the primary caregivers them-
elves. We further inquired if the main caregiver received support
f other informal caregivers and to which extent these additional
aregivers were involved in care and supervision. A detailed de-
cription of the procedure is reported in Neubauer et al. [23].
We assumed that after dementia diagnosis the patients’ need
or support in daily life would increase over time. Therefore we
athered information how much time family members spent per
ay on care giving tasks. We assessed the ability of study partici-
ants to independently perform activities of daily living (ADL) –
uch as eating, bathing, dressing, etc. – via Barthel-Index [24]. This
ool is based on a 0-to-100 scale with higher scores indicating less
eed for support, but a clear cut-off point does not exist. Tasks
uch as light housework, preparing meals, shopping or managing
oney are referred to as instrumental activities of daily living
IADL). We estimated the patients’ capability to handle these tasks
ith IADL subscale of the nurses’ observation scale for geriatric
atients (NOSGER) [25]. In this scale from 5 to 25 points higher
cores are associated with higher impairment.
Cost assessment
We included all services covered by the German statutory health
insurance in our analysis and summarized them as “formal health
care services.” Moreover we valued the time informal caregivers
dedicated to patients for care and supervision to assess the sub-
stantial impact of informal care on total costs of dementia care.
Utilization patterns within all cost categories were docu-
mented based on following sources of information: With regard to
formal health care services, insurance claims data provided by
AOK Bavaria Health Insurance Fund was evaluated. Time dedi-
cated to informal care was assessed in yearly telephone interviews
with the main caregivers, discerning hours provided for support in
ADL, IADL and supervision respectively. However, when it came to
assigning financial values to care giving hours we decided not to
include supervision hours because the caregivers reported some
difficulties to precisely discern between hours dedicated to ADL
and IADL and those explicitly dedicated to supervision only [23].
After withdrawal of consent, no further data was collected, the
dropouts were disregarded, and the cost estimation included all
383 remaining participants. The observation period started for
each patient individually at point of recruitment in order to ac-
count for the extended recruitment phase.
To describe the costs of care for a dementia patient from health
insurance perspective only expenditures for services provided as
documented in insurance claims data are relevant. For societal
perspective valued informal care has to be considered addition-
ally. Our cost data included information from 2005 to 2008. Within
societal perspective, we inflated costs to 2008-prices using the
gross domestic product (GDP) deflator in order to reach a common
base year. Because health insurance expenditures do not reflect
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cided not to inflate costs in health insurance perspective.
Specifics concerning formal health care services
Formal health care services consist of inpatient care in hospitals,
outpatient treatment by physicians (this includes general practi-
tioners as well as specialists), drug prescriptions, rehabilitation,
medical aids, non-physician services and home health care which
are covered by the German statutory health insurance. Moreover
we included all services paid by the compulsory long-term care
insurance. We assessed health insurance expenditures for 24
months based on claims data and calculated costs per year. When-
ever an observation period started or ended during a treatment
(e.g., hospital stays), we distributed time to the distinctive phases.
Accordingly, costs were attributed proportionally to time of re-
source use implying constant amounts per day.
Because in the German social security system physicians bill
their services quarterly, not monthly, costs for outpatient treat-
ment were reported quarterly starting with the quarter of study
entry. Physician services are brought to account via a fee for ser-
vice system that settles a specific score for each service. The mon-
etary value of physician services is calculated by multiplying this
score with a point value that varies by quarter and by the physi-
cian’s area of specialization. We converted the score documented
for each quarter into Euro amounts by applying the corresponding
monetary point values as reported by the Association of Statutory
Health Insurance Physicians of Bavaria.
Our analysis included all prescribed drugs. 2008 pharmacy re-
tail prices for the majority of drugs are available via the Scientific
Institute of the AOK (WIdO). For these drugs cost inflation was not
necessary. Referring to drugs not listed in the WIdO database we
inflated insurance’s expenditures using the GDP deflator. Societal
costs were then calculated by subtracting discounts as ruled by the
Social Security Code.
Within the German hospital sector the concept of “dual financ-
ing” brings about that health insurance only has to pay for hospital
treatment itself, whereas costs for hospital infrastructure are bal-
anced by state’s government. From societal perspective capital
costs for inpatient care have to be considered but corresponding
information is not reported in insurance claims data. As suggested
by the “Working Group Methods in Health Economic Evaluation”
we assumed capital costs of € 55- (2001 value) per day [26] inflated
to 2008 and added this amount to treatment costs.
The compulsory long-term care insurance offers a special ser-
vice called “Pflegegeld” (allowance for nursing care). It represents a
transfer payment to informal caregivers that is paid if they per-
form care giving tasks instead of professional nursing services. For
societal perspective, we subtracted the expenditures for “allow-
ance for nursing care” from total health insurance’s expenditures
in the long-term care sector. Tariffs of the compulsory long-term
care insurance did not change during the study period, thus no
inflation was performed.
Specifics concerning informal care time
To assess informal care giving time, trained interviewers con-
ducted interviews with the main caregivers at baseline and after
12 and 24 months. We asked how many hours the main caregiver
as well as other informal caregivers dedicated to the patient on an
average day. The time all informal caregivers together spent on
ADL, IADL and supervision within the last 4 weeks [23,27] was
assessed with an extended version of the specific questions in the
resource utilization in dementia (RUD) instrument [28].
We assumed a minimum of 6 hours sleep and limited infor-
mal care giving time to a maximum of 18 hours per day. Super-
vision hours were not considered in our baseline analysis but in
a sensitivity analysis because a clear differentiation between dhours dedicated to care and hours dedicated to supervision was
not possible [23].
Time spent on informal care is usually valued with the oppor-
tunity cost approach or the replacement cost approach respec-
tively. We assumed that dementia patients had to rely on profes-
sional help if no informal caregiver was available and decided
therefore on the replacement cost approach.
We applied per hour wage rates of professional home nursing
staff at €28.30 (ADL) [29] or professional housekeepers resulting in
€16.64 (IADL) [30]. If the main caregiver and the dementia patient
did not live within the same household, travel expenses of €3.40
per day [29] were added. Time dedicated to supervision was valued
with the wage rate of a professional housekeeper, too. Because
corresponding amounts reflected the results of a sensitivity anal-
ysis, we did not subsume valued supervision time under valued
informal care but reported these costs separately.
Within a second sensitivity analysis we estimated opportunity
costs of informal care. In this context, different recommendations
which proxy to use exist [26,31–34]. We distinguished employable
caregivers and retired caregivers, choosing the statutory retire-
ment age of 65 years as cut-off point. As suggested by Working
Group Methods in Health Economic Evaluation, opportunity costs
of employable caregivers were priced with the modified net wage
rate [26], which was 17.05 €/h in 2008. Opportunity costs of retired
caregivers were estimated on 7.61 €/h, the net wage rate of a pro-
fessional housekeeper, which slightly differed from Posnett’s pro-
posal to impute the wage rate of a home help [33].
The care giving time was assumed to develop in a linear way
between the interviews. After an event – which was defined as
nursing home placement for at least 4 weeks or death of the de-
mentia patient – no further interview took place. In these cases we
predicted hours devoted to care giving tasks based on a calculation
of the average increase in informal care giving time for complete
cases and applied this increase to incomplete patients until time
of drop-out. If none of the three interviews was performed, time at
baseline was estimated according to base data on patient’s status
examination and health insurance data. The average changes doc-
umented for complete cases served for calculating care giving
hours for follow-up interviews and single missing interviews as
described above for drop-outs.
Statistical analysis
The objective of our analysis was to investigate costs of dementia
care per year spent in community setting. Whenever a patient
died or permanently moved to a nursing home no further data was
obtained. To derive estimates per person-year, observed costs
were adjusted to a 1-year time frame by dividing costs by the time
spent in community setting. For example, costs of a patient who
lived at home for the entire 2 years were divided by 2, whereas
costs of a patient who moved to a nursing home after 6 months
were divided by 0.5. In the analyses, patients were then
weighted with the proportion of the 2 years study period they
lived at home [35].
We compared total costs per person-year and costs within each
category for patients with mild and moderate dementia. P values
ere examined performing 1000 nonparametric bootstrap replica-
ions, which account for the highly skewed distribution of cost
ata.
In order to adjust differences in total costs between mild and
oderate dementia for age and gender, a generalized linear mixed
odel assuming a gamma distribution with log link was used. The
ecruiting general practitioner was included as a random effect to
ake into account cluster-randomization. We had implicitly as-
umed that worsening dementia symptoms and comorbidity are
o some extend related. Thus we did not adjust for comorbidity
ecause this additional cofactor might have covered the impact of
ementia on existing comorbid conditions.
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830 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 8 2 7 – 8 3 5We performed the Ramsey Regression Equation Specification
Error test and the Hosmer-Lemeshow test to check for specifica-
tion errors and systematic bias respectively, but both tests indi-
cated no problems (P  0.75 and 0.80, respectively).
An alternative approach would be the use of the Heckman se-
lection model, which also allows assessing potential selection
bias. As the selection model assumes normality and has been
shown to be sensitive to violations of this assumption, and as
there is no selection bias problem in our model of actual expendi-
tures, we chose the two-part model instead.
To analyze differences within individual cost categories, the
same approach was followed for the categories outpatient treat-
ment, drug prescriptions and informal care, where costs were in-
curred by almost every patient. For the few patients without costs
in one of these categories we assigned small positive values so
they were not dropped from the analyses.
For cost components with a higher percentage of patients
with zero costs, two-part regression models were conducted as
recommended by Manning [36]. The first part used logistic re-
ression to predict the probability of positive costs, while in the
econd part a gamma model with log link was applied to analyze
he amount of positive expenditures as described for total costs.
ge, gender and random effects for the recruiting general prac-
itioner were again included in both stages. Overall cost esti-
ates were then obtained by multiplying expected probabilities
f positive costs from the first stage with predicted costs from
he second stage. To examine group differences, recycled pre-
ictions were used, which generate predictions based on the
oefficient of interest – in this context disease stage - adjusted
or age and gender [37].
Due to the stepwise analysis costs as estimated in the regres-
ion model do not equal the sum of estimated mean costs in the
istinct cost categories. Moreover the stepwise approach does not
llow the provision of one single P value as proof for statistical
relevance. Thus two P values were reported, the first referring to
tatistically significant differences in probability of service use,
he second referring to statistically significant cost differences
mongst service users. We assumed a significant cost difference
n patient level, if at least one of the two P values turned out to be
ignificant.
Table 1 – Patient characteristics and care giving environme
Patient characteristics and care giving
environment at baseline
Entire st
sampl
N 383
Age 80.4 (6,8
Sex (% female) 68.1%
Previous dementia diagnosis (in %) 68.9%
Age of main caregiver 59.2 (13
Sex of main caregiver (% female) 72.1%
Relation to main caregiver % of spouses 31.1%
Relation to main caregiver % of children (in law) 60.3%
Household with main caregiver 66.1%
Support of other caregivers available 62.2%
MMSE 18.7 (3.8
Barthel index 73.3 (26
NOSGER-IADL 15.8 (5.3
ADL hours per day at baseline 1.8 (2.2
IADL hours per day at baseline 2.4 (2.0
Supervision hours per day at baseline 2.4 (4.6
Data are mean (SD).
ADL, activities of daily living; IADL, instrumental ADL; MMSE, mini-m
patients.
* Statistical significance at 5% level tested by 2-test for distinct variablesRegarding the volume of service use, we adjusted utilization pat-
erns with time spent in community setting and applied weights as
escribed for cost data above. We adjusted differences in service use
or all service categories for age and gender applying a generalized
inear mixed model assuming a negative binomial distribution with
og link. The recruiting general practitioner was again included as a
andom effect to take into account cluster-randomization.
A significance level of 5% was used for all analyses and all
nalyses were performed with the software package SAS, version
.2 (Cary, NC).
Results
Patients’ characteristics and care giving environment
As shown in Table 1, the subsamples with mild and moderate
dementia were comparable regarding age and gender structure as
well as concerning their living environment. In contrast, system-
atic baseline differences in Barthel-Index and NOSGER IADL oc-
curred which indicated a higher level of impairment within mod-
erate cases. This corresponded with the observation that family
caregivers of patients with moderate dementia dedicated signifi-
cantly more time to care and supervision tasks. In addition, more
patients with moderate dementia had received a diagnosis of their
disease prior to study entry.
Care giving turned out to be a women’s domain that in first line
wives and daughters (in law) got involved with: less than 10% of
our interview partners reported to be neither spouses nor children
(in law) of the dementia patient. Because the mean age of the
dementia patients was around 80 years, caring spouses and chil-
dren themselves were already advanced in years.
At the end of the study period 256 patients (66.8%) were still
living in community setting. Sixty-six (17.2%) had died and an-
other 61 (15.9%) had moved to a nursing home. In moderate de-
mentia we observed 54 events (34 cases of death; 20 institutional-
izations) and in mild dementia there were 73 events (46 cases of
death; 27 institutionalizations).
t baseline.
Mild dementia Moderate
dementia
P value*
247 135
80.0 (6.7) 81.1 (6.8) 0.11
69.0% 66.7% 0.65
61.3% 83.0% <0.0001
58.4 (13.3) 60.6 (14.3) 0.13
73.4% 69.6% 0.43
28.7% 35.7% 0.16
64.1% 53.3% 0.04
64.1% 69.6% 0.27
59.7% 68.1% 0.10
21.1 (1.7) 14.3 (2.3) <0.0001
79.4 (22.8) 62.0 (29.1) <0.0001
14.3 (5.0) 18.7 (4.5) <0.0001
1.2 (1.7) 2.9 2.6) <0.0001
2.1 (2.0) 3.0 (2.1) <0.0001
1.8 (4.0) 3.4 (5.4) <0.0001
-status examination; NOSGER, nurses’ observation scale for geriatricnt a
udy
e
)
.7)
)
.5)
)
)
)
)
entaland by Kruskal-Wallis test for continuous variables.
c831V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 8 2 7 – 8 3 5Per capita costs from societal and from health insurance
perspective
Predicted costs of care per community-living dementia patient
amounted to more than €47,700 per year from societal perspective.
As illustrated in Figure 1, the major cost component was valued
are giving time with an economic impact of around €38,200. The
amount assigned to informal care was approximately the fourfold
of costs for formal health care services, which summed up to circa
€9.600. This means that around 80% of total costs in community-
based dementia care could be assigned to informal care.
Within the opportunity cost based sensitivity analysis costs of
informal care were reduced by circa €15,100 and their share of total
costs reached approximately 70%.
Because informal care is not reflected in health insurance’s
expenditures, costs of dementia care in this perspective totaled
only a minor share of societal costs. They equaled around €10,200
Euros, whereupon hospital treatment (€3045), long-term care ser-
vices (€2941), and drug prescriptions (€1584) covered almost 75% of
the entire expenditures.
Due to methodological differences in cost assessment, sub-
stantial discrepancies in societal and insurance perspective
were observed in the hospital and the long-term care sector:
Because capital costs of hospital treatment are not accounted
for in health insurance perspective, expenditures for hospital
treatment were considerably lower than the calculated societal
costs (  €896; 28.5%). Contrary insurance expenditures for
long-term care equaled twice the societal costs (  €1506;
104.9%) because “allowance for nursing care” was taken into
consideration.
Societal costs within distinct cost categories according to
disease stage
To receive a first impression, we calculated costs of dementia care
in community setting according to disease severity without ad-
justing for age, gender and cluster effects. Based on 1000 nonpara-
metric bootstrap replications, this baseline calculation indicated
significantly higher costs for patients with moderate dementia
Fig. 1 – Costs components (in Euros) of dementia care from s
according to the generalized linear mixed model with gamm(P  0.001). With regard to the different services categories weobserved a significant cost variation in informal care (P  0.001)
and long-term care (P  0.001).
The generalized linear mixed model confirmed the finding that
costs of care increased with progressing dementia, especially in
informal care. Table 2 highlights the corresponding results based
on two P values. The first indicates differences in probability of
service use and the second indicates cost differences amongst ser-
vice users. In informal care, outpatient treatment and drug pre-
scriptions as well as for the bundle of formal health care services
the probability of service use exceeded 98%. That is why for these
categories only one P value was reported.
Table 3 combines the two steps of the regression model and
reports the estimated costs per year in community setting on pa-
tient level adjusted for age, gender and cluster-effects.
Costs attributable to a patient with moderate dementia
amounted to €62,797 from societal perspective which was around
1.5-fold the costs attributable to a patient with mild dementia. The
latter summed up to €39,967.
Within both subgroups informal care was the crucial cost
driver, accounting for €52,335 (83.3%) in patients with moderate
and for €30,803 (77.1%) in patients with mild dementia. Concerning
the utilization of formal health care services, the amount assigned
to patients with moderate dementia was higher, too: The entire
bundle of services amounted to € 10,496, whereas the correspond-
ing value in mild dementia totaled €9,183.
Our sensitivity analysis with opportunity costs estimated eco-
nomic value of informal care to be €19,715 in mild and €29,701 in
moderate dementia. This was a reduction of 36.0% respectively
43.2% compared to the baseline analysis. This decline did not af-
fect results with regard to content. Informal care remained the
main cost driver within both subgroups and the difference be-
tween mild and moderate dementia was still highly significant
(P  0.0001).
Patients with moderate dementia caused higher costs in most
service categories and tended to use formal health care services
more often than patients with mild dementia as illustrated in Table 4.
tal perspective adjusted for age, gender, and cluster-effects
stribution.ocie
a diHowever, regarding hospital care, outpatient treatment and reha-
lds sl
832 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 8 2 7 – 8 3 5bilitation procedures we observed more frequent service utiliza-
tion and higher costs in the latter subgroup.
Overall, caring for a person with moderate dementia was sig-
nificantly more costly than caring for a person with mild dementia
(P  0.0001). This result based on a disproportional difference in
valued care giving time (P 0.0001). Valued informal care varied by
69.9% when a patient with moderate dementia was compared to a
patient with mild dementia. The variation of costs for formal health
care service utilization in patients with moderate dementia com-
pared to those with mild dementia was much smaller with 14.3%.
This difference remained statistically insignificant (P 0.19).
Discussion
Overall, our study findings affirm the initial assumption that de-
teriorating disease severity is associated with rising health care
costs: We observed highly significant cost differences in informal
care and long-term care, a narrowly significant difference in drug
Table 2 – Costs of dementia care from societal perspective
cluster-effects based on the generalized linear mixed mod
Mild dementia (n  248)
User Percentage of
users (Step 1)
Mean cost pe
user (Step 2)
Informal care 246 99.2% 30,803€
Costs of supervision* 116 46.8% 19,832€
Long-term care 125 50.4% 2083€
Physician visits 248 100.0% 969€
Drug prescriptions 247 99.6% 1520€
Inhospital stays 167 67.3% 6378€
Nonphysician services 96 38.7% 625€
Medical aids 184 74.2% 382€
Home health care 81 32.7% 1793€
Rehabilitation 28 11.3% 2216€
Formal health care Service
utilization‡
248 100.0% 9183€
Total costs‡ 248 100.0% 39,967€
If only P value is reported prediction based on one-step-model, other
* Results of sensitivity analysis; amount not included in overall cost
‡ Result of model estimation; Addition of mean cost per category yie
Table 3 – Cost per patient according to disease severity fro
effects based on the generalized linear mixed model with
Adjusted mean cost per patient per year
in community setting
Mild dem
(n  2
Informal care 30.80
Costs of supervision* 10.25
Long-term care 96
Physician visits 96
Drug prescriptions 1.52
Inhospital stays 4.11
Nonphysician services 24
Medical aids 28
Home health care 52
Rehabilitation 23
Formal health care service utilization‡ 9.18
Total costs‡ 39.96
Data are means based on recycled predictions.
* Results of sensitivity analysis; amount not included in overall cost
‡ Result of model estimation; addition of mean cost per category yields incosts as well as a trend towards higher costs for patients with
moderate dementia in most other cost units.
Contrary to our expectations the argument of rising costs ac-
cording to disease stage was not confirmed for inpatient treat-
ment, outpatient treatment and rehabilitation procedures, where
slightly higher costs were reported for patients with mild demen-
tia. Curative medicine and treatment of acute illnesses has seem-
ingly still a high impact for patients in this stage of the disease. In
patients with moderate dementia these aspects of care are obviously
of minor relevance and instead components of continuous support
in daily living – such as informal care, long-term care, or home health
care – gain importance. This argumentation is in line with our sec-
ondary hypothesis that in course of disease progression the relevant
cost units of dementia care change due to a rising need for care.
The IDA study has several strengths but also some limitations.
An advantage of our approach is patient enrollment via general
practitioners. In Germany, health insurance is compulsory and
free access to health care services is possible with a physician’s
rding to disease severity adjusted for age, gender, and
th gamma distribution.
Moderate dementia (n  135) P values
er Percentage of
users (Step 1)
Mean cost per
user (Step 2)
P 1 probability
of service use
P 2 costs
per user
3 98.5% 52,335€ — <0.0001
6 71.1% 28,922€ 0.001 0.01
1 82.2% 2912€ 0.02 0.06
5 100.0% 952€ — 0.84
3 98.5% 1786€ — 0.05
5 70.4% 5176€ 0.52 0.12
4 32.6% 926€ 0.52 0.11
4 77.0% 518€ 0.87 0.08
1 45.2% 2464€ 0.11 0.16
2 8.9% 2221€ 0.35 0.99
5 100.0% 10,496€ — 0.19
5 100.0% 62,797€ — <0.0001
a two-step model was applied.
ightly different figures.
cietal perspective adjusted for age, gender, and cluster-
ma distribution.
ia Moderate dementia
(n  135)
Cost difference
52.335€ Significant
20.841€ Significant
2.367€ Significant
952€ NS
1.786€ Significant
3.526€ NS
327€ NS
391€ NS
962€ NS
165€ NS
10.496€ NS
62.797€ Significantacco
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833V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 8 2 7 – 8 3 5referral. Thus almost every patient in advanced age has physician
contacts during the year. IDA GPs received intense training on
dementia diagnosis, leading to the detection of 119 new dementia
cases – one-fifth moderate cases – among their long-time patients.
Hence, we are convinced that our recruitment strategy avoids the
risk of a preselected patient clientele as it is probable when re-
cruiting via neurological specialists or memory and university
clinics, respectively and accounts well for patients in early stage of
dementia, where no specialized treatment is undergone yet. The
comparatively high share of newly detected dementia cases is on
the other hand a hint that many community-living people in ad-
vanced age who suffer from dementia are known to the health
care system but not as dementia patients. A routine check-up for
cognitive impairment is seemingly no part of usual treatment be-
cause it is a sensitive issue in the patient-physician-relationship
[38]. Tabooing dementia is a vulnerable source of concern for
sound incidence/prevalence estimates or precise cost predictions,
which can hardly be dispelled by any kind of study design.
Compared with other international studies that consider pri-
mary information, we analyzed one of the largest samples of com-
munity-living dementia patients: Rigaud and colleagues [6] based
heir cost estimates on only 50 Alzheimer patients and other stud-
es generally observed between 100 and 250 patients [3,12,21,39–
3]. Scuvee-Moreau et al. [16] reported about 386 people suffering
rom dementia, including 168 institutionalized individuals. Codu-
as et al. [5] interviewed 560 individuals but started recruitment at
the age of 50 years. Our analyses refer to 383 dementia patients,
thus we assume the presented results to be less prone to single
outliers that use to occur when skewed cost data are evaluated.
We assessed stage-dependant costs of dementia care within
various health care sectors based on a combination of primary
data and insurance claims data. This is a more comprehensive
way of cost assessment than in most previous studies which ei-
ther relied on insurance claims data or on interviews. Schulenburg
et al. [40] had chosen a similar approach, obtaining their cost in-
ormation from individualized patient records provided by general
ractitioners. However, treatment by specialists that was not due
o referral might have been underestimated. Our cost assignment
ia individualized insurance claims data accounts for each single
ervice that was paid for by the statutory health insurance. There-
ore the reported utilization patterns are not affected by common
eaknesses of self-reported data collected within interviews such
s misunderstanding or memory decay [44]. Moreover primary
data obtained from interviews have to be extrapolated to per year
figures [3,8]. The accuracy of these estimates depends on whether
the recall period is representative for the entire year and on
whether imputed unit costs reflect different types of services used
sufficiently.
The crucial limitation of insurance claims data is that they can
Table 4 – Service utilization per patient according to diseas
and cluster-effects based on the generalized linear mixed
Adjusted utilization pattern of formal health care
services per year in community setting
M
Number of physician visits
Number of drug prescriptions
Number of inhospital days
Number of prescribed nonphysician services
Number of prescribed medical aids
Number of prescribed home health care services
Number of days on rehabilitation
Statistical significance at 5% level.
Data are means based on recycled predictions.
* P value based on general linear mixed model with negative binomionly detect utilization of services covered by the statutory healthinsurance but do not allow any conclusion on out-of-pocket pay-
ments. Germany’s social health insurance system contains a broad
range of various health related services and thus self-financed
health services used to be of minor relevance. We assume that the
presented figures slightly underestimate the direct costs of de-
mentia care but given the legal framework at that time, we con-
sider neglecting out-of-pocket payments to be tolerable. Recently,
the statutory health insurance in Germany has bit by bit restricted
reimbursement of medical aids and drugs, thus out-of-pocket pay-
ments will without doubt gain relevance for future studies.
Insurance claims data as second weak points do not reflect
informal care because time dedicated to a patient represents a
non-cash item. Therefore all studies exclusively working with
insurance claims data disregard the substantial impact of val-
ued informal care in costs of dementia care. In this context,
collecting information on care giving time of all informal care-
givers is a further strength of our study that allows a more
realistic estimation of societal costs than studies that only re-
gard care giving time of the main caregiver (as example see
[8,43]). Previous work on IDA data, suggests an underestimation
of care giving time up to 10% if the support of additional care-
givers is disregarded [27].
Claims data lack information on disease severity and the de-
mentia patients’ general condition. Primary data sources in con-
trast enable investigation of cognition status, functional depen-
dency level, occurrence of disruptive behavior as well as
sociodemographic information. Costs of dementia care do not de-
pend on cognition as a single item [7,8,42]but are the result of
complex mutual interaction mechanisms between cognition,
function, behavior, care setting, concurrent comorbid conditions,
service utilization patterns, and prescription habits. The latter el-
ements are traceable in claims data. Hence, if a precise model to
predict costs and prospective course of dementia disorders is en-
visaged, primary data and secondary data have to be linked. IDA
data provide a suitable initial point for corresponding analyses.
However, the main interest of this article was to describe costs of
care within distinct subsets of dementia patients and not to de-
velop a cost prediction model.
The validity of our study results might be cut back by the un-
derlying inclusion criteria of the IDA study. Thus our sample might
not be fully representative for the entire population of communi-
ty-living dementia patients.
The first inclusion criterion was membership of the “AOK
Health Insurance Fund.” We are convinced that relying only on
patients insured with AOK Bavaria will not be a critical source of
potential error, because AOK Bavaria Health Insurance Fund had a
market share of 49.6% in people aged 65 years and older in the
study region in 2005.
The second inclusion criterion was an MMSE score from 10 to
verity from societal perspective adjusted for age, gender,
el with negative binomial distribution.
mentia
248)
Moderate dementia
(n  135)
P value*
5.3 45.8 0.83
4.4 39.9 0.06
3.6 11.5 0.40
2.0 2.5 0.36
2.9 3.4 0.21
2.1 3.1 0.17
1.5 1.2 0.71
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834 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 8 2 7 – 8 3 5less than 10 were not included in our study. According to findings
of Souetre and collaborators [39] within this subgroup costs of
ommunity-based care, notably those of informal care, are consid-
rably higher than in mild and moderate dementia. The dispro-
ortionate need for informal care in severe dementia cases is
ikely to reach the edge of informal caregivers’ capacities. We hy-
othesized that the majority of severe dementia cases is already
nstitutionalized in nursing homes, considering deteriorating dis-
ase stage as a predictor for nursing home placement which cor-
esponds to findings of Knopman et al. [45] and Wilson et al. [46].
The third inclusion criterion was “support of an informal care-
giver.” Because the primary aim of the IDA study was to examine
whether a family counseling program can delay nursing home
placement, dementia patients without informal caregivers were
excluded. We assume patients without family support have to rely
on professional services such as home nurses or housekeepers.
Therefore, in the community setting, this patient clientele is sup-
posed to cause higher expenditures for formal health care services
than dementia patients with family support.
We are aware that above all the risk of selection bias is inherent
and we might not have addressed all community-living dementia
patients in an adequate manner. Study participation was voluntarily.
Thus we cannot exclude that community-living dementia patients
who decided not to take part in IDA differed from those who enrolled.
We estimated costs of dementia care per community-living
patient in Germany on €47,747. According to disease severity, we
alculated €39,967 in mild and €62,797 in moderate dementia.
These results fit well with the cost assessment of Hallauer and
colleagues [17], which equals around €48,000 in 2008 values.
Our figures, however, considerably exceed those of Leon and
Neuman [21], who reported for the USA costs of approximately
€5600 (2008 values) in mild and of approximately €20,100 in mod-
erate dementia. Informal care was valued via replacement costs
with the average wage rate of a home-help as proxy. According to
their study, informal care covers around 63% of total costs com-
pared with around 80% in our findings. In contrast, Ersék et al. [47]
assessed informal costs of dementia care in Hungary based on
opportunity costs. They priced forgone time of non-working care-
givers with the minimal salary and calculated for employed care-
givers the productivity loss [47]. That way, the economic value of
informal care is €2100 in mild and €2400 in moderate dementia
covering around 50% respectively 33% of total costs. Other studies
differentiated opportunity costs of lost leisure time and forgone
working hours [43], assigned small flat-rate amounts [8] or relied
on the caregivers’ individual wage rate [42]. These approaches led
altogether to more conservative cost estimates than ours. Given
the comparatively high German wage level and the fact that infor-
mal caregivers probably spend more time on performing care giv-
ing tasks than professionals [48], our estimation represents an
upper limit for costs of informal care.
Regarding formal health care services, our cost calculation is
remarkably lower than the estimation of Wolstenholme and col-
laborators [3] for the United Kingdom. We observed around €9,200
n mild and around €10,500 in moderate dementia, whereas they
eported costs around €12,400 and €23,400 (2008 values), respec-
ively, to almost 70% attributable to nursing home costs. ICTUS-
tudy calculated direct costs of community-based dementia care
round €5200 (2008 value) in Western Europe [8]. This is just 50% of
he insurance expenditures documented for IDA. Zhao et al. [9]
reported expenditures of €11,700 (2008 value) per Alzheimer pa-
ient based on US Medicare claims, which comes closer to our
ssessment of €10,200.
The observations indicate that the scientific community so far
lacks a common understanding how to value informal care, which
would be a basic requirement to improve the comparability of
results. The impact of informal care unambiguously depends on
the underlying costing assumption, thus we recommend ratherlooking at time dedicated to ADL, IADL and supervision than at
values assigned to these tasks. Obviously, an extrapolation of pri-
mary data to per year figures [3,8] leads to lower estimations of
formal health care costs than a complete assessment of yearly
expenditures out of claims data ([9], our results). Despite the de-
scribed limitations, we think insurance claims present factual ser-
vice utilization more precisely.
Altogether the differing results in dementia related cost of ill-
ness studies raise the question, if cost data are transferable be-
tween different decades and countries because standards of care
change, legal frameworks differ and after all costing methods also
vary. We expect utilization patterns similar to our results in health
care systems where a broad range of different health care services
is available with only little copayment and anticipate comparable
costs in settings with similar price level and likewise attitudes
towards informal care. The underlying methodological approach
can be transferred without any reservation.
Conclusions
Caring for community-living patients with moderate dementia
causes higher costs than caring for patients with mild dementia,
both from health insurance and societal perspective. Valued infor-
mal care is the substantial part of community-based dementia
care from societal perspective and covers around 80% of total
costs. In a stage-dependant comparison, costs of informal care in
moderate dementia exceed costs of informal care in mild demen-
tia by around €21,500, whereas costs for formal health care ser-
vices only differ by around €1300.
Informal care provided by family members in community set-
ting is a noncash item saving expenditures for professional care.
Because staying at home as long as possible is in the best interest
of both the dementia patient and the social security system, con-
cepts fostering community-based dementia care and support to
family caregivers need to be further developed.
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